Cite
MLA Citation
C. Hart et al.. “Biomodulatory metronomic therapy in stage IV melanoma is well‐tolerated and may induce prolonged progression‐free survival, a phase I trial.” Journal of the European Academy of Dermatology and Venereology, vol. 30, n.d., pp. e119–e121. http://access.bl.uk/ark:/81055/vdc_100038789955.0x00000a